Summary
- Current Price
- MRSN price is unknown, with unknown change on
- Current Price All-Time High
- MRSN price vs all-time high is unknown
- Market Cap
- MRSN market cap is unknown, with unknown 1-year change
- PE Ratio
- MRSN PE ratio is unknown
- Revenue
- MRSN current annual revenue is $40.50M, up +9.88% year-over-year
- Next Earnings
- As of today, the next earnings release for MRSN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Mersana Therapeutics, Inc. |
| Ticker | NASDAQ: MRSN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | mersana.com |
| Employees | 102 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $40M | ||
| Revenue, 1Y Change | +9.88% | |
| -$14.12 | ||
| EPS, 1Y Change | -854.76% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$14.12 | ||
| EPS Estimate | N/A | -$14.31 |
| EPS Est. Change | N/A | -1.37% |
| $40.50M | ||
| Revenue Estimate | N/A | $18.85M |
| Revenue Est. Change | N/A | -53.45% |
| - | ||
| Price Target | - | $30.75 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.48 | -$1.48 | +0.10% | |
| -$0.61 | -$14.12 | -2,221.74% | |
| -$14.31 | N/A | -1.37% | |
| -$11.11 | N/A | +21.30% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $40.92M | $36.86M | -9.93% | |
| $31.03M | $40.50M | +30.49% | |
| $18.85M | N/A | -53.45% | |
| $58.05M | N/A | +43.33% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +9.88% | ||
| +94,079.07% | ||
| -854.76% | ||
| -485.88% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $40.50M | ||
| -$14.12 | ||
| $38.87M | ||
| 95.98% | ||
| -$73.34M | ||
| -181.09% | ||
| -$69.19M | ||
| -170.86% | ||
| -$63.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -2.47 | ||
| 2.19 | ||
| 2.19 | ||
| - | ||
| 3 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$9.51M | ||
| $107.75M | ||
| $144.66M | ||
| $136.90M | ||
| $154.17M | ||
| $62.46M | ||
| $28.65M | ||
| $16.40M | ||
| $4.33M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $113.83M | ||
| $113.83M | ||
| $1.63M | ||
| $40.81M | ||
| $1.63M | ||
| $0.00 | ||
| $418.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$82.34M | ||
| $11.44M | ||
| $4.09M | ||
| $132.00K | ||
| -$82.47M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Truist Securities | → | |
| BTIG | → | |
| Truist Securities | → | |
| Guggenheim | → | |
| Truist Securities | → | |
| Guggenheim | → | |
| William Blair | ||
| Citigroup | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with MRSN
FAQ
What is the ticker symbol for Mersana Therapeutics, Inc.?
The ticker symbol for Mersana Therapeutics, Inc. is NASDAQ:MRSN
Does Mersana Therapeutics, Inc. pay dividends?
No, Mersana Therapeutics, Inc. does not pay dividends
What sector is Mersana Therapeutics, Inc. in?
Mersana Therapeutics, Inc. is in the Healthcare sector
What industry is Mersana Therapeutics, Inc. in?
Mersana Therapeutics, Inc. is in the Biotechnology industry
What country is Mersana Therapeutics, Inc. based in?
Mersana Therapeutics, Inc. is headquartered in United States
When did Mersana Therapeutics, Inc. go public?
Mersana Therapeutics, Inc. initial public offering (IPO) was on June 28, 2017
Is Mersana Therapeutics, Inc. in the S&P 500?
No, Mersana Therapeutics, Inc. is not included in the S&P 500 index
Is Mersana Therapeutics, Inc. in the NASDAQ 100?
No, Mersana Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Mersana Therapeutics, Inc. in the Dow Jones?
No, Mersana Therapeutics, Inc. is not included in the Dow Jones index
When was Mersana Therapeutics, Inc. last earnings report?
Mersana Therapeutics, Inc.'s most recent earnings report was on March 3, 2026
When does Mersana Therapeutics, Inc. report earnings?
The date for Mersana Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MRSN Official Website www.mersana.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1442836/000162828025052202/0001628280-25-052202-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1442836/000162828025009246/0001628280-25-009246-index.htm
- MRSN Profile on Yahoo Finance finance.yahoo.com/quote/MRSN
- MRSN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrsn